Laboratory and clinical experience with recombinant plasminogen activator
Builder, S.E.; Grossbard, E.
Progress in Clinical and Biological Research 211: 303-313
1986
ISSN/ISBN: 0361-7742 PMID: 3083430 Document Number: 273225
Document emailed within 1 workday
Related Documents
Nelles, L.; Lijnen, H.R.; Van Nuffelen, A.; Demarsin, E.; Collen, D. 1990: Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA) Thrombosis and Haemostasis 64(1): 53-60Jia, X.F.; Hong, Z.; Fan, J.H.; Zhang, Y.M. 2016: Clinical effect of mechanical fragmentation combined with recombinant tissue plasminogen activator artery thrombolysis on acute cerebral infarction Journal of Biological Regulators and Homeostatic Agents 30(3): 821-826
Fincke, U.; Schneider, J.; Friderichs, E.; Giertz, H.; Flohé, L. 1988: Enhanced myocardial salvage by combined treatment with recombinant single-chain urokinase-type plasminogen activator and recombinant human superoxide dismutase in a canine coronary thrombosis model Arzneimittel-Forschung 38(1): 138-142
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576
Yamada, R.; Yamada, S.; Ishii, A.; Tane, S. 1993: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy Nippon Ganka Gakkai Zasshi 97(8): 955-960
De Moerloose, P.; Mermillod, N.; Amiral, J.; Reber, G. 1998: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1 Thrombosis and Haemostasis 79(3): 554-556
Glas-Greenwalt, P.; Hall, J.M.; Panke, T.W.; Kant, K.S.; Allen, C.M.; Pollak, V.E. 1986: Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura Journal of Laboratory and Clinical Medicine 108(5): 415-422
Fukao, H.; Yamamoto, K.; Matsuo, O. 1991: Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome Rinsho Byori. Japanese Journal of Clinical Pathology 39(7): 720-726
Shiba, E.; Kobayashi, T.; Yayoi, E.; Takatsuka, Y.; Koyama, H.; Takai, S.; Mori, T. 1992: Measurement of plasminogen activator and plasminogen activator inhibitor in breast cancer tissue: preliminary report Nihon Geka Gakkai Zasshi 93(1): 109
Wallnöfer, A.E.; van Griensven, J.M.; Schoemaker, H.C.; Cohen, A.F.; Lambert, W.; Kluft, C.; Meijer, P.; Kooistra, T. 1993: Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans Thrombosis and Haemostasis 70(6): 1005-1008
Topol, E.J. 1989: Recombinant tissue plasminogen activator: implications in therapy Seminars in Hematology 26(3 Suppl 3: 25-31
Al-Buhairi, A.R.; Jan, M.M. 2002: Recombinant tissue plasminogen activator for acute ischemic stroke Saudi Medical Journal 23(1): 13-19
Al-Buhairi, A.R.; Jan, M.M. 2002: Recombinant tissue plasminogen activator for acute ischemic stroke Neurosciences 7(1): 7-13
Harris, R.; Frade, L.G.; Creighton, L.J.; Gascoine, P.S.; Alexandroni, M.M.; Poole, S.; Gaffney, P.J. 1988: Investigation by HPLC of the catabolism of recombinant tissue plasminogen activator in the rat Thrombosis and Haemostasis 60(1): 107-112
Virji, M.A.; Aggarwal, S.; Kang, Y. 1989: Alterations in plasminogen activator and plasminogen activator inhibitor levels during liver transplantation Transplantation Proceedings 21(3): 3540-3541
Schermer, E.; Streif, W.; Genser, N.; Frühwirth, M.; Trawöger, R.; Simma, B. 2000: Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series Wiener Klinische Wochenschrift 112(21): 927-933
Aleshkov, S.B.; Ustav, M.B.; Baev, A.A. 1991: Expression of human tissue plasminogen activator by recombinant cell lines from various animals Molekuliarnaia Biologiia 25(5): 1226-1238
Dodd, I.; Fears, R.; Robinson, J.H. 1986: Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator Thrombosis and Haemostasis 55(1): 94-97
Wang, S.P.; Liu, C.P.; Charng, M.J.; Chou, C.Y.; Tsai, J.H.; Pan, J.P.; Shyong, W.C.; Chan, W.L.; Kong, C.W.; Chang, M.S. 1989: The efficacy and safety of recombinant tissue plasminogen activator infusion in acute myocardial infarction Zhonghua Yi Xue Za Zhi 43(4): 223-228